Diagnosing the Hurdles in the Medical Device Regulatory Landscape
CVE/FIRST VulnCon 2025 · Main Stage
This talk delves into the complex and rapidly evolving regulatory landscape surrounding the integration of Artificial Intelligence (AI) into medical devices, primarily focusing on the United States and the European Union. Presented by representatives from a health sector Information Sharing Analysis Center (ISAC), the session highlights the significant hurdles manufacturers face in navigating disparate global standards, particularly concerning patient safety, data privacy, and the inherent risks of AI technologies. The core message emphasizes the critical balance between fostering innovation and establishing robust ethical and security frameworks to mitigate potential harms.
AI review
A policy/regulatory overview talk from a health-sector ISAC on AI in medical devices that covers real terrain — FDA pathways, EU AI Act risk tiers, adversarial ML basics — but executes at the level of a well-researched Wikipedia article rather than an expert briefing. The speakers are clearly competent policy trackers, not researchers or practitioners who have been inside the problem. The adversarial ML content is textbook-shallow (the panda/FGSM example is a decade-old pedagogy staple, not a novel threat framing), the regulatory coverage adds nothing a compliance attorney couldn't pull from…